What's holding many back isn't reluctance—it's simply not knowing
Each winter, a familiar-seeming virus quietly claims hundreds of lives among Australia's oldest citizens — not because medicine lacks an answer, but because the question hasn't yet reached enough ears. In 2025, nearly 500 Australians aged 75 and over died from respiratory syncytial virus, a pathogen long underestimated as a seasonal nuisance. Australia has responded by placing a free RSV vaccine into its National Immunisation Program, and the early signs — strong uptake intentions, a measurable drop in childhood cases — suggest that awareness, not reluctance, is the final barrier standing between this intervention and its full potential.
- RSV killed nearly 500 Australians over 75 in just nine months of 2025, exposing a dangerous gap between public perception of the virus and its true severity.
- Health authorities and medical groups are racing to reframe RSV before another winter peaks — not as a bad cold to endure, but as a preventable threat demanding action.
- A free vaccine is already available through the National Immunisation Program for those 75 and over, and for Aboriginal and Torres Strait Islander people from age 60, yet many eligible Australians remain unaware it exists.
- The maternal vaccine program offers a proof of concept: over 225,000 pregnant women vaccinated since early 2024 helped drive RSV cases in young children down by more than nine percent in a single year.
- With 60 percent of eligible Australians already vaccinated or planning to be, the campaign's remaining work is one of reach rather than persuasion — a public health messaging challenge, not a trust crisis.
Respiratory syncytial virus arrives each winter wearing the disguise of an ordinary cold — a cough, a fever, some congestion. For most people, it passes without consequence. For Australians aged 75 and over, it can mean pneumonia, hospitalisation, or death. In the first nine months of 2025 alone, nearly 500 people in that age group died from severe RSV, and more than 21,000 reported confirmed cases. These figures are quietly driving one of Australia's most important public health campaigns of the season.
RSV Awareness Week, coordinated by the Australian Medical Association and the Immunisation Foundation of Australia, is built around a single corrective message: this is not just a bad cold. AMA president Danielle McMullen put it plainly — too many Australians still underestimate what RSV can do, and that misperception shapes whether they seek protection. A virus you think you'll simply endure is a virus you won't vaccinate against.
The good news is that protection now exists and is freely available. RSV vaccines entered Australia's National Immunisation Program with federal funding, offered at no cost to people 75 and older, and to Aboriginal and Torres Strait Islander people from age 60. Early uptake looks promising: a survey of over 1,000 eligible Australians found 60 percent had already been vaccinated or planned to be, and nearly two-thirds considered RSV vaccination as important as an annual flu shot.
The maternal program, running since February 2024, has already demonstrated what's possible. More than 225,000 pregnant women received the vaccine to shield their newborns during their most vulnerable early months, and RSV cases in young children fell by over nine percent between 2024 and 2025. The numbers confirm the vaccines work in practice, not just in trials.
Still, awareness remains the critical gap. Immunisation Foundation founder Catherine Hughes observed that what's holding many eligible Australians back isn't doubt or hesitancy — it's simply not knowing the vaccine exists or that it's free. That distinction matters enormously. Changing minds is hard; delivering information to people who are ready to act on it is far more tractable. The race now is to reach those millions before the cold months deepen.
Respiratory syncytial virus doesn't announce itself as a killer. It arrives in winter like any other respiratory bug—a cough, a fever, congestion. For most people, it passes. For others, particularly the very old, it becomes something far more serious: pneumonia, hospitalisation, death. In the first nine months of 2025, nearly 500 Australians aged 75 and over died from severe RSV. More than 21,000 in that age group reported confirmed cases. These numbers are driving a quiet but urgent campaign from Australia's health authorities, who are trying to convince older Australians that a free vaccine now available to them is worth getting before winter arrives.
The push comes as part of RSV Awareness Week, a coordinated effort by the Australian Medical Association and the Immunisation Foundation of Australia to reframe how the public understands this virus. "Too many people still think RSV is just a bad cold, but for some Australians it can be far more serious than that," said Danielle McMullen, president of the medical association. The perception matters because it shapes behaviour. A bad cold is something you endure. A virus that hospitalises thousands and kills hundreds is something you protect yourself against.
RSV vaccines entered Australia's National Immunisation Program with federal funding, making them free for people 75 and older, and for Aboriginal and Torres Strait Islander people aged 60 and over. The rollout is still relatively new, but early data suggests uptake is strong. A survey of just over 1,000 eligible Australians found that 60 percent have already been vaccinated or intend to get the shot soon. Nearly two-thirds of respondents rated RSV vaccination as important as an annual flu shot—a significant endorsement for a vaccine many had never heard of a year ago.
The maternal vaccine, introduced earlier, offers a window into what's possible. Since February 2024, more than 225,000 pregnant women have received an RSV vaccine designed to protect their newborns in those vulnerable first months of life. The effect has been measurable: RSV cases in young children dropped by more than nine percent between 2024 and 2025, falling from 86,000 to 78,000. It's a concrete demonstration that the vaccines work, that they reduce real illness in real people.
Yet awareness remains the bottleneck. Catherine Hughes, founder of the Immunisation Foundation of Australia, noted that many eligible older Australians simply don't know the vaccine exists or that it's free. "What's holding many back isn't reluctance; it's simply not knowing the vaccine exists or that it's now free," she said. This is, in some ways, an easier problem to solve than vaccine hesitancy. It's not about changing minds; it's about reaching people with information they need. The challenge now is ensuring that message reaches the millions of Australians who could benefit before the next winter season arrives.
Notable Quotes
Too many people still think RSV is just a bad cold, but for some Australians it can be far more serious than that— Danielle McMullen, president of the Australian Medical Association
What's holding many back isn't reluctance; it's simply not knowing the vaccine exists or that it's now free— Catherine Hughes, founder of the Immunisation Foundation of Australia
The Hearth Conversation Another angle on the story
Why does RSV hit older people so much harder than younger ones?
The immune system weakens with age. Your lungs become less efficient at clearing infection. What a 30-year-old shakes off in a week can turn into pneumonia in someone 80.
And the maternal vaccine—that's protecting babies born to vaccinated mothers?
Exactly. The mother passes antibodies to the baby through pregnancy and early breastfeeding. It gives newborns protection during their most fragile months, when RSV can be life-threatening.
The survey found 60 percent already vaccinated or planning to get it. That sounds high for a new vaccine.
It is. But remember, that's among people who were aware enough to respond to a survey about it. The real number of eligible Australians who know about the vaccine is probably lower.
So the health authorities aren't fighting hesitancy—they're fighting invisibility.
Precisely. If you're 76 and your GP mentions it, you'll probably get it. But if you've never heard of it, you can't choose to get it.
What does nearly 500 deaths in nine months actually mean for the healthcare system?
It means hospital beds occupied, ICU resources stretched, families making end-of-life decisions. It means preventable suffering when a vaccine exists.